Verax Biomedical Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Verax Biomedical Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6497
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Verax Biomedical Inc (Verax) is a developer of rapid tests for the detection of bacterial contaminants in tissues for transplantation, blood components, and cellular therapies. The company’s products include platelet pgd test, red cell pgd test and cell therapy PGD test. It uses the PGD technology to conduct its tests. Verax’s product platelet pgd test is used for the detection of bacterial contamination in platelets. Verax uses pan genera detection (PGD) technology during quality control testing to develop tests in order to detect the bacteria in blood components. The company operates through its laboratory facility located in Marlborough, the US. Verax is headquartered in Marlborough, Massachusetts, the US.

Verax Biomedical Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Verax Biomedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Verax Biomedical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Verax Biomedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Verax Biomedical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Verax Biomedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Verax Biomedical Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Verax Biomedical Raises USD11.4 Million in Venture Financing 10
Verax Biomedical Raises USD12.6 Million in Venture Financing 11
Verax Biomedical Raises USD4 Million in Venture Financing 12
Verax Biomedical Raises US$12 Million In Venture Financing 13
Verax Biomedical Raises US$6.8 Million In Venture Financing 14
Verax Biomedical Raises Additional US$0.5 Million In Venture Financing 15
Verax Biomedical Raises USD2.8 Million in Venture Financing 16
Partnerships 17
Verax Biomedical Renews its Commercialization Agreement with Fresenius Kabi USA 17
Verax Biomedical Inc – Key Competitors 18
Verax Biomedical Inc – Key Employees 19
Verax Biomedical Inc – Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Verax Biomedical Inc, Medical Equipment, Key Facts 2
Verax Biomedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Verax Biomedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Verax Biomedical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Verax Biomedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Verax Biomedical Inc, Deals By Market, 2012 to YTD 2018 8
Verax Biomedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Verax Biomedical Raises USD11.4 Million in Venture Financing 10
Verax Biomedical Raises USD12.6 Million in Venture Financing 11
Verax Biomedical Raises USD4 Million in Venture Financing 12
Verax Biomedical Raises US$12 Million In Venture Financing 13
Verax Biomedical Raises US$6.8 Million In Venture Financing 14
Verax Biomedical Raises Additional US$0.5 Million In Venture Financing 15
Verax Biomedical Raises USD2.8 Million in Venture Financing 16
Verax Biomedical Renews its Commercialization Agreement with Fresenius Kabi USA 17
Verax Biomedical Inc, Key Competitors 18
Verax Biomedical Inc, Key Employees 19

List of Figures
Verax Biomedical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Verax Biomedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Verax Biomedical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Verax Biomedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Verax Biomedical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Verax Biomedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Verax Biomedical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Verax Biomedical Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cellectis SA (ALCLS):医療機器:M&Aディール及び事業提携情報
    Summary Cellectis SA (Cellectis) is a clinical-stage biopharmaceutical company that research, develop and commercialise rational genome engineering technologies. The company pioneers gene editing company, deploying core proprietary technologies to develop off-the-shelf immunotherapies to target and …
  • Graham Holdings Company (GHC):企業の財務・戦略的SWOT分析
    Graham Holdings Company (GHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Gammon India Ltd (GAMMONIND):企業の財務・戦略的SWOT分析
    Gammon India Ltd (GAMMONIND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Central Electricity Generating Co:企業の戦略的SWOT分析
    Central Electricity Generating Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Retail Food Group Limited (Foodservice):企業の戦略・SWOT・財務情報
    Retail Food Group Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Retail Food Group Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Quantum Genomics SA (ALQGC):製薬・医療:M&Aディール及び事業提携情報
    Summary Quantum Genomics SA (Quantum Genomics) is a biopharmaceutical company which develops novel medicines in the field of cardiovascular diseases. The company develops drugs to treat high blood pressure and heart failure. Its research programs are based on the Brain Aminopeptidase A Inhibition (B …
  • Sumitomo Dainippon Pharma Co Ltd (4506):製薬・医療:M&Aディール及び事業提携情報
    Summary Sumitomo Dainippon Pharma Co Ltd (Sumitomo Dainippon), a subsidiary of Sumitomo Chemical Co., Ltd, develops manufacturers, purchases, sells, imports and exports pharmaceutical products. The company focuses on major therapeutic areas which include central nervous system (CNS), cardiovascular, …
  • Clinigen Group Plc (CLIN)-製薬・医療分野:企業M&A・提携分析
    Summary Clinigen Group plc (Clinigen Group) is a pharmaceutical and services company that provides access to medicines, clinical trials, unlicensed and commercial supply. The company acquires and licenses essential commercial medicines including cardioxane, ethyol, foscavir, savene and vibativ. It o …
  • ReShape Medical Inc-製薬・医療分野:企業M&A・提携分析
    Summary ReShape Medical Inc (ReShape Medical) is a medical device company that offers weight loss solutions. The company provides dual intragastric balloon for weight loss. Its product comprises of ReShape Duo, a non surgical dual-intragastric balloon used in the treatment of obese or overweight pat …
  • TESCO Personal Finance Group Ltd:企業の戦略・SWOT・財務情報
    TESCO Personal Finance Group Ltd - Strategy, SWOT and Corporate Finance Report Summary TESCO Personal Finance Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • ActiveCare Inc (ACAR):企業の財務・戦略的SWOT分析
    Summary ActiveCare Inc (ActiveCare) is a medical equipment company that monitors health analytics. The company provides monitoring component to traditional disease management and wellness solutions. It offers solutions such as diabetes supplies, online web-based administrative tools, browser and iPh …
  • Boyd Gaming Corporation:企業の戦略・SWOT・財務分析
    Boyd Gaming Corporation - Strategy, SWOT and Corporate Finance Report Summary Boyd Gaming Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • General Re Corporation:企業の戦略・SWOT・財務情報
    General Re Corporation - Strategy, SWOT and Corporate Finance Report Summary General Re Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Globe Telecom Inc (GLO):企業の財務・戦略的SWOT分析
    Globe Telecom Inc (GLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Arion Bank hf.:企業の戦略・SWOT・財務情報
    Arion Bank hf. - Strategy, SWOT and Corporate Finance Report Summary Arion Bank hf. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Clayton Homes Inc:企業の戦略・SWOT・財務情報
    Clayton Homes Inc - Strategy, SWOT and Corporate Finance Report Summary Clayton Homes Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • CBIZ Inc (CBZ):企業の財務・戦略的SWOT分析
    Summary CBIZ Inc (CBIZ) is a provider of financial and advisory services. It offers accounting and tax; and insurance and human resource solutions. The company offers accounting and tax services such as audit and assurance, tax consulting and advisory services. Its insurance and human resource servi …
  • WntResearch AB (WNT):製薬・医療:M&Aディール及び事業提携情報
    Summary WntResearch AB (WntResearch) is a biotechnology company that develops novel anti-metastatic therapies for the treatment of cancer. The company's development stage products include Foxy-5 and Box-5. Its lead project, Foxy-5, a peptide which is in Phase I clinical development for reconstitutin …
  • Cembra Money Bank AG:企業の戦略・SWOT・財務情報
    Cembra Money Bank AG - Strategy, SWOT and Corporate Finance Report Summary Cembra Money Bank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bio-Rad Laboratories Inc (BIO):企業の財務・戦略的SWOT分析
    Bio-Rad Laboratories Inc (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆